Seer (SEER) FCF Margin Growth (3y) (2023 - 2026)
Seer (SEER) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Seer |
99.67 Mn |
99.67 Mn |
982,000.00 |
-7,097.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-7,097.00 |
| Dec 31, 2025 |
-5,600.00 |
| Sep 30, 2025 |
24,919.00 |
| Jun 30, 2025 |
3,778.00 |
| Mar 31, 2025 |
33,731.00 |
| Dec 31, 2024 |
25,731.00 |
| Sep 30, 2024 |
12,431.00 |
| Jun 30, 2024 |
55,830.00 |
| Mar 31, 2024 |
2.50 Mn |
| Dec 31, 2023 |
-37,343.00 |
| Sep 30, 2023 |
837,920.00 |
| Jun 30, 2023 |
981,839.00 |
| Mar 31, 2023 |
298,524.00 |
